Testing for hypertrophic cardiomyopathy is primarily recommended for individuals with a first-degree relative diagnosed with the condition, as well as for people experiencing symptoms like chest pain, ...
SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of EARTH-HCM (Epidemiology, Awareness, Real-world Treatment and ...
Hypertrophic cardiomyopathy (HCM) is a long-term genetic condition that thickens the heart muscle and reduces blood flow. Early diagnosis can lower risks like sudden cardiac death, heart failure, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results